Fucci focuses on diligence and negotiations of new investment opportunities, portfolio company management, and investor relations. Currently, he serves on ...
Investor Relations. Troy Osborn +1 817-345-6844 ir@biospartners.com. Companies Seeking Investment. Tim Van Treuren, PhD +1 817-345-6829 opportunities@ ...
The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial ...
Missing: bios | Show results with:bios
The Investor Relations website contains information about Avid Bioservices, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: bios | Show results with:bios
Investors. BioSyent is a publicly traded specialty pharmaceutical company. Our issued and outstanding common shares are listed for trading on the TSX Venture ...
Missing: bios | Show results with:bios
Download Bio-Rad annual reports, SEC filings, and quarterly results. Get investor kits, corporate information, and answers to company and stock FAQs.
Investor Presentation. NASDAQ: BIOS. Q1 2020. Page 2. ©2019 Option Care Health ... identified in our reports as filed with the SEC. Any forward-looking statement ...
Apr 11, 2024 · Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our ...
Missing: bios | Show results with:bios
BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results. DENVER , March 15, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip ...
3 days ago · This is a remote contract role for an Investor Relations Associate with experience in Biotech and Life Sciences. The Associate will be ...